US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

First Tracks Biotherapeutics Inc

38.42

-1.1500-2.91%

Volume:6K

Turnover:239.79K

Market Cap:1.37B

PE:-8.48

High:40.69

Open:39.35

Low:38.42

Close:39.57

52wk High:49.91

52wk Low:14.72

Shares:35.73M

Float Shares:34.75M

Volume Ratio:0.42

T/O Rate:0.02%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-4.5296

ROE:-48.91%

ROA:-28.97%

PB:8.13

PE(LYR):- -

Loading ...

Overview Company News Filings

First Tracks Biotherapeutics Director Ware J. Anthony Sells 39,265 Shares Worth $1.76 Million

First Tracks Biotherap Price Target Maintained with a $57.00/Share by HC Wainwright & Co.

Analyst Reiterates Buy on TRAX as IL-15/CD122 Data De-Risk Celiac Program; $57 Price Target Maintained

First Tracks Biotherapeutics Inc (TRAX) Receives a Rating Update from a Top Analyst

Piper Sandler Sticks to Its Buy Rating for First Tracks Biotherapeutics Inc (TRAX)

First Tracks Biotherapeutics to Join Wells Fargo Healthcare Conference Fireside Chat

Analysts Offer Insights on NA Companies: Arcturus Therapeutics (ARCT), EquipmentShare.com, Inc. (EQPT) and First Tracks Biotherapeutics Inc (TRAX)

First Tracks Biotherapeutics Inc : JP Morgan Raises Target Price to $65 from $30

THOMSON REUTERS

First Tracks Biotherapeutics Analysts Increase Their Forecasts After Q2 Results

Benzinga Earnings

First Tracks Biotherap Price Target Raised to $57.00/Share from $44.00 by HC Wainwright & Co.

Barclays Sticks to Its Buy Rating for First Tracks Biotherapeutics Inc (TRAX)

First Tracks Biotherapeutics Inc : Piper Sandler Raises Target Price to $95 from $54

THOMSON REUTERS

First Tracks Q2 EPS $(0.95) Up From $(1.47) YoY

Benzinga Earnings

First Tracks Q2 FY26 Net Loss Narrows to $33.37 Million

Press Release: First Tracks Biotherapeutics Announces Second Quarter 2026 Financial Results and Provides Business Update

First Tracks Biotherap Price Target Raised to $65.00/Share from $45.00 by UBS

UBS Adjusts First Tracks Biotherapeutics PT to $65 From $45, Maintains Buy Rating

MT Newswires Live

First Tracks Biotherapeutics Inc : UBS Raises Target Price to $65 from $45

THOMSON REUTERS

First Tracks Biotherapeutics Inc. : Wells Fargo Raises Target Price to $55 from $30

THOMSON REUTERS

First Tracks Biotherapeutics Inc (TRAX) Gets a Buy from Wells Fargo

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnest.com/stock/TRAX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"TRAX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TRAX\",,,,,undefined,":{"symbol":"TRAX","market":"US","secType":"STK","nameCN":"First Tracks Biotherapeutics Inc","latestPrice":38.42,"timestamp":1789047447320,"preClose":39.57,"halted":0,"volume":6111,"delay":0,"changeRate":-0.029062421026029784,"floatShares":34748800,"shares":35730843,"eps":-4.529554,"marketStatus":"Trading","change":-1.15,"latestTime":"09-10 09:37:36 EDT","open":39.35,"high":40.6916,"low":38.42,"amount":239789.541222,"amplitude":0.057407,"askPrice":40,"askSize":207,"bidPrice":38.51,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-4.529554,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789070400000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":39.57,"preHourTrading":{"tag":"盘前","latestPrice":41,"preClose":39.57,"latestTime":"07:14 EDT","volume":105,"amount":4169.800215,"timestamp":1789038877635,"change":1.43,"changeRate":0.036138,"amplitude":0.032853},"postHourTrading":{"tag":"盘后","latestPrice":39.57,"preClose":39.57,"latestTime":"19:30 EDT","volume":4915,"amount":194667.76,"timestamp":1788996608210,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.418658,"impliedVol":0.9659,"impliedVolPercentile":0.8118},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TRAX\",,,,,undefined,":{"symbol":"TRAX","floatShares":34748800,"roa":"-28.97%","roe":"-48.91%","lyrEps":0,"volumeRatio":0.418658,"shares":35730843,"dividePrice":0,"high":40.6916,"amplitude":0.057407,"preClose":39.57,"low":38.42,"week52Low":14.72,"pbRate":"8.13","week52High":49.9114,"institutionHeld":0,"latestPrice":38.42,"committee":-0.017199,"eps":-4.529554,"divideRate":0,"volume":6111,"delay":0,"ttmEps":-4.529554,"open":39.35,"prevYearClose":20,"prevWeekClose":40.46,"prevMonthClose":41.84,"prevQuarterClose":20.12,"fiveDayClose":45.28,"twentyDayClose":46.13,"sixtyDayClose":17.88},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TRAX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-12","symbol":"TRAX","fiscalQuarterEnding":"2026/06","expectedEps":-0.74,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786507200000,"reportTimeType":"post","actualEps":-0.95}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TRAX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TRAX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":9,"updateTime":1787112000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TRAX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TRAX","date":"2026-09-09","current":-8.766868,"percent":0.258065,"low":-10.141689,"twenty":-9.393656,"median":-4.289122,"eighty":-3.52395,"high":-3.156022,"avg":-6.082288,"sd":2.693739,"marketCap":1493549237},"quantilePoints":[{"date":"2026-04-24","current":-3.975194,"twenty":-3.975194,"median":-3.975194,"eighty":-3.975194,"marketCap":660227979},{"date":"2026-05-01","current":-4.868566,"twenty":-4.868566,"median":-4.085034,"eighty":-3.799448,"marketCap":808605530},{"date":"2026-05-08","current":-3.728313,"twenty":-4.68236,"median":-4.236719,"eighty":-3.799448,"marketCap":619224346},{"date":"2026-05-15","current":-3.799448,"twenty":-4.433387,"median":-4.031683,"eighty":-3.799448,"marketCap":631038952},{"date":"2026-05-22","current":-3.452672,"twenty":-4.299486,"median":-3.855938,"eighty":-3.664859,"marketCap":584796305},{"date":"2026-05-29","current":-3.259026,"twenty":-4.249272,"median":-3.799448,"eighty":-3.475745,"marketCap":551997467},{"date":"2026-06-05","current":-3.749322,"twenty":-4.203244,"median":-3.738817,"eighty":-3.411676,"marketCap":635041334},{"date":"2026-06-12","current":-3.508294,"twenty":-4.109513,"median":-3.726221,"eighty":-3.329068,"marketCap":594217248},{"date":"2026-06-18","current":-3.743141,"twenty":-4.020386,"median":-3.683399,"eighty":-3.361617,"marketCap":633994562},{"date":"2026-06-26","current":-3.372329,"twenty":-3.945066,"median":-3.663829,"eighty":-3.37851,"marketCap":571188276},{"date":"2026-07-02","current":-3.829664,"twenty":-3.955109,"median":-3.663829,"eighty":-3.376449,"marketCap":648649362},{"date":"2026-07-10","current":-6.674616,"twenty":-4.112294,"median":-3.726221,"eighty":-3.397462,"marketCap":1130513144},{"date":"2026-07-17","current":-7.459502,"twenty":-4.261943,"median":-3.735727,"eighty":-3.424655,"marketCap":1263453116},{"date":"2026-07-24","current":-7.754091,"twenty":-4.794084,"median":-3.774042,"eighty":-3.434543,"marketCap":1313349220},{"date":"2026-07-31","current":-9.842999,"twenty":-6.999282,"median":-3.799448,"eighty":-3.441135,"marketCap":1667157964},{"date":"2026-08-07","current":-9.334163,"twenty":-7.464446,"median":-3.842801,"eighty":-3.45844,"marketCap":1580973783},{"date":"2026-08-14","current":-9.814035,"twenty":-7.742967,"median":-3.975194,"eighty":-3.486045,"marketCap":1573229017},{"date":"2026-08-21","current":-9.33927,"twenty":-8.651869,"median":-4.081492,"eighty":-3.504998,"marketCap":1497122321},{"date":"2026-08-28","current":-9.97229,"twenty":-9.339073,"median":-4.144854,"eighty":-3.509324,"marketCap":1598597915},{"date":"2026-09-04","current":-9.475235,"twenty":-9.448042,"median":-4.257739,"eighty":-3.516946,"marketCap":1518918135},{"date":"2026-09-09","current":-9.31698,"twenty":-9.393656,"median":-4.289122,"eighty":-3.52395,"marketCap":1493549237}],"updateTime":1789047456326},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TRAX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2665518733","title":"First Tracks Biotherapeutics Director Ware J. Anthony Sells 39,265 Shares Worth $1.76 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2665518733","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665518733?lang=en_us&edition=fundamental","pubTime":"2026-09-05 04:26","pubTimestamp":1788553584,"startTime":"0","endTime":"0","summary":"First Tracks Biotherapeutics director Ware J. Anthony sells 39,265 shares worth $1.76 millionDirector Ware J. Anthony sold 39,265 shares of First Tracks Biotherapeutics common stock on Sep. 2, 2026 at","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nNDL6QkCmS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"First Tracks Biotherapeutics Director Ware J. Anthony Sells 39,265 Shares Worth $1.76 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRAX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664719138","title":"First Tracks Biotherap Price Target Maintained with a $57.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2664719138","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664719138?lang=en_us&edition=fundamental","pubTime":"2026-09-03 19:54","pubTimestamp":1788436440,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TRAX/analyst-ratings","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TRAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664875485","title":"Analyst Reiterates Buy on TRAX as IL-15/CD122 Data De-Risk Celiac Program; $57 Price Target Maintained","url":"https://stock-news.laohu8.com/highlight/detail?id=2664875485","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664875485?lang=en_us&edition=fundamental","pubTime":"2026-09-03 18:15","pubTimestamp":1788430541,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Emily Bodnar maintained a Buy rating on First Tracks Biotherapeutics Inc today and set a price target of $57.00. Emily Bodn...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/analyst-reiterates-buy-on-trax-as-il-15-cd122-data-de-risk-celiac-program-57-price-target-maintained-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/analyst-reiterates-buy-on-trax-as-il-15-cd122-data-de-risk-celiac-program-57-price-target-maintained-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TRAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664820584","title":"First Tracks Biotherapeutics Inc (TRAX) Receives a Rating Update from a Top Analyst","url":"https://stock-news.laohu8.com/highlight/detail?id=2664820584","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664820584?lang=en_us&edition=fundamental","pubTime":"2026-09-03 16:36","pubTimestamp":1788424591,"startTime":"0","endTime":"0","summary":"Barclays analyst Etzer Darout maintained a Buy rating on First Tracks Biotherapeutics Inc today and set a price target of $65.00. According to TipR...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/first-tracks-biotherapeutics-inc-trax-receives-a-rating-update-from-a-top-analyst-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/first-tracks-biotherapeutics-inc-trax-receives-a-rating-update-from-a-top-analyst-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TRAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662023627","title":"Piper Sandler Sticks to Its Buy Rating for First Tracks Biotherapeutics Inc (TRAX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2662023627","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662023627?lang=en_us&edition=fundamental","pubTime":"2026-08-27 19:56","pubTimestamp":1787831774,"startTime":"0","endTime":"0","summary":"In a report released today, Yasmeen Rahimi from Piper Sandler maintained a Buy rating on First Tracks Biotherapeutics Inc, with a price target of $...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/piper-sandler-sticks-to-its-buy-rating-for-first-tracks-biotherapeutics-inc-trax-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/piper-sandler-sticks-to-its-buy-rating-for-first-tracks-biotherapeutics-inc-trax-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TRAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662658744","title":"First Tracks Biotherapeutics to Join Wells Fargo Healthcare Conference Fireside Chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2662658744","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662658744?lang=en_us&edition=fundamental","pubTime":"2026-08-27 04:18","pubTimestamp":1787775501,"startTime":"0","endTime":"0","summary":"First Tracks Biotherapeutics to join Wells Fargo Healthcare Conference fireside chatFirst Tracks Biotherapeutics will join the Wells Fargo Healthcare Conference in Boston on Sept. 9, 2026, with a 9:30","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL40fj87:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TRAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660893052","title":"Analysts Offer Insights on NA Companies: Arcturus Therapeutics (ARCT), EquipmentShare.com, Inc. (EQPT) and First Tracks Biotherapeutics Inc (TRAX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2660893052","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660893052?lang=en_us&edition=fundamental","pubTime":"2026-08-20 19:20","pubTimestamp":1787224836,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the NA sector with new ratings on Arcturus Therapeutics (ARCT), EquipmentShare.com, Inc. (EQPT) and First T...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-arcturus-therapeutics-arct-equipmentshare-com-inc-eqpt-and-first-tracks-biotherapeutics-inc-trax-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-arcturus-therapeutics-arct-equipmentshare-com-inc-eqpt-and-first-tracks-biotherapeutics-inc-trax-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARCT","BK4141","TRAX","EQPT","NA","BK4104","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660279495","title":"First Tracks Biotherapeutics Inc : JP Morgan Raises Target Price to $65 from $30","url":"https://stock-news.laohu8.com/highlight/detail?id=2660279495","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660279495?lang=en_us&edition=fundamental","pubTime":"2026-08-18 23:33","pubTimestamp":1787067181,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nFWN44F0OV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TRAX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659415767","title":"First Tracks Biotherapeutics Analysts Increase Their Forecasts After Q2 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2659415767","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659415767?lang=en_us&edition=fundamental","pubTime":"2026-08-13 21:07","pubTimestamp":1786626443,"startTime":"0","endTime":"0","summary":"TRAX reported narrower Q2 loss of 95 cents per share. Analysts raised price targets for the stock, citing potential for ANB033 in immune diseases.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/analyst-stock-ratings/price-target/26/08/61173753/first-tracks-biotherapeutics-analysts-increase-their-forecasts-after-q2-results","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRAX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659155006","title":"First Tracks Biotherap Price Target Raised to $57.00/Share from $44.00 by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2659155006","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659155006?lang=en_us&edition=fundamental","pubTime":"2026-08-13 18:59","pubTimestamp":1786618740,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TRAX/analyst-ratings","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRAX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659013203","title":"Barclays Sticks to Its Buy Rating for First Tracks Biotherapeutics Inc (TRAX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659013203","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659013203?lang=en_us&edition=fundamental","pubTime":"2026-08-13 16:25","pubTimestamp":1786609539,"startTime":"0","endTime":"0","summary":"Barclays analyst Etzer Darout maintained a Buy rating on First Tracks Biotherapeutics Inc today and set a price target of $65.00. Darout covers the...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/barclays-sticks-to-its-buy-rating-for-first-tracks-biotherapeutics-inc-trax-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/barclays-sticks-to-its-buy-rating-for-first-tracks-biotherapeutics-inc-trax-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TRAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659839180","title":"First Tracks Biotherapeutics Inc : Piper Sandler Raises Target Price to $95 from $54","url":"https://stock-news.laohu8.com/highlight/detail?id=2659839180","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659839180?lang=en_us&edition=fundamental","pubTime":"2026-08-13 11:37","pubTimestamp":1786592223,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nFWN4491AL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TRAX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659513188","title":"First Tracks Q2 EPS $(0.95) Up From $(1.47) YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2659513188","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659513188?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:38","pubTimestamp":1786567120,"startTime":"0","endTime":"0","summary":"First Tracks (NASDAQ:TRAX) reported quarterly losses of $(0.95) per share. This is a 35.37 percent increase over losses of $(1.47) per share from the same period last year.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61160312/first-tracks-q2-eps-0-95-1-47-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"First Tracks Q2 EPS $(0.95) Up From $(1.47) YoY","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QLD","IYW","GPIQ","QQQ","MNQmain","QQQM",".IXIC","BK4139","TECS","SQQQ","QQQE","QDTE","TQQY","QID","FTEC","TRAX","PSQ","JEPQ","NDX","TQQQ","ONEQ","QQQJ","QQQA","QQQY","QYLG","NQmain","NVIW.SI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659918900","title":"First Tracks Q2 FY26 Net Loss Narrows to $33.37 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659918900","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659918900?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:18","pubTimestamp":1786565937,"startTime":"0","endTime":"0","summary":"First Tracks Q2 FY26 net loss narrows to $33.37 millionFirst Tracks posted a Q2 net loss of $33.4 million, narrowing 21.36% from a $42.4 million loss a year earlier.Loss per share improved to $0.95 fr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDL7xKFl0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","SG9999014005.SGD","SG9999014021.USD","IE00B3QW5Z07.USD","SG9999014039.USD","BCDF","BK4112","NDAQ","SG9999014013.SGD","BK4588","LU0314104364.USD","LU2095319765.USD","TRAX","IE00B64PRP62.GBP","BK4139","IE00BGHQF748.EUR","IE00BN0W2T93.GBP","LU2210149790.SGD","LU2210150020.SGD","IE00BN0W2W23.USD","BK4585","IE00BN0W2V16.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659009089","title":"Press Release: First Tracks Biotherapeutics Announces Second Quarter 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2659009089","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659009089?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:15","pubTimestamp":1786565700,"startTime":"0","endTime":"0","summary":"-- Completed enrollment for Cohort 1  of Phase 1b ANB033. trial in celiac disease ; top-line Cohort 1 data reaffirmed for Q4. -- Cohort 2  enhanced to enroll up to 40 patients including. those with a broad range of histologic  and symptom. severity to further inform future development; top-line Cohort 2 data. -- U.S. FDA granted Fast Track designation for ANB033 for the treatment of. -- Enrollment ongoing for Phase 1b ANB033 trial in eosinophilic esophagitis. -- Reiterating cash-runway into Q2 2028, including the expansion of ANB033. -- U.S. FDA granted Fast Track designation to ANB033 for the. treatment of people with CeD on a gluten-free diet. -- 70-patient trial assessing one dose level of subcutaneously. -- Cohort 1  is a gluten-challenge study to assess the. -- Cohort 2  assesses the possibility of mucosal healing","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4077","SLE","RA","TRAX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658951302","title":"First Tracks Biotherap Price Target Raised to $65.00/Share from $45.00 by UBS","url":"https://stock-news.laohu8.com/highlight/detail?id=2658951302","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658951302?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:26","pubTimestamp":1786393560,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TRAX/analyst-ratings","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRAX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658317769","title":"UBS Adjusts First Tracks Biotherapeutics PT to $65 From $45, Maintains Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2658317769","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658317769?lang=en_us&edition=fundamental","pubTime":"2026-08-10 21:29","pubTimestamp":1786368555,"startTime":"0","endTime":"0","summary":"First Tracks Biotherapeutics (TRAX) has an average rating of Buy and mean price target of $53.25, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research f","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TRAX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658931559","title":"First Tracks Biotherapeutics Inc : UBS Raises Target Price to $65 from $45","url":"https://stock-news.laohu8.com/highlight/detail?id=2658931559","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658931559?lang=en_us&edition=fundamental","pubTime":"2026-08-10 21:10","pubTimestamp":1786367459,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nAZN4TD0K4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TRAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654300379","title":"First Tracks Biotherapeutics Inc. : Wells Fargo Raises Target Price to $55 from $30","url":"https://stock-news.laohu8.com/highlight/detail?id=2654300379","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654300379?lang=en_us&edition=fundamental","pubTime":"2026-07-28 18:26","pubTimestamp":1785234413,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nAZN4TAB3Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TRAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654071064","title":"First Tracks Biotherapeutics Inc (TRAX) Gets a Buy from Wells Fargo","url":"https://stock-news.laohu8.com/highlight/detail?id=2654071064","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654071064?lang=en_us&edition=fundamental","pubTime":"2026-07-28 15:35","pubTimestamp":1785224115,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Derek Archila from Wells Fargo maintained a Buy rating on First Tracks Biotherapeutics Inc, with a price target of ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/first-tracks-biotherapeutics-inc-trax-gets-a-buy-from-wells-fargo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/first-tracks-biotherapeutics-inc-trax-gets-a-buy-from-wells-fargo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0154236417.USD","LU0980610538.SGD","LU0640476718.USD","LU0070302665.USD","LU0052756011.USD","LU0128525689.USD","LU1074936037.SGD","LU0211327993.USD","BK4588","LU0162691827.USD","LU0211328371.USD","LU1280957306.USD","LU0029864427.USD","KBWB","LU0048573561.USD","LU0289960550.SGD","LU0130102774.USD","IYF","LU0072461881.USD","LU1814569148.SGD","TRAX","LU0251142724.SGD","LU0708994859.HKD","LU0971096721.USD","LU1267930490.SGD","LU0648001328.SGD","FTXO","IE00B19Z3B42.SGD","LU0106831901.USD","LU1267930573.SGD","LU0320765489.SGD","LU1363072403.SGD","LU0130517989.USD","LU0208291251.USD","LU0314106906.USD","LU0149725797.USD","LU2236285917.USD","LU0310799852.SGD","LU0787776722.HKD","LU1201861249.SGD","LU1035773651.USD","TFNS","LU0175139822.USD","LU0477156953.USD","IE0002270589.USD","LU0942090050.USD","BK4207","LU0251131958.USD","LU0267386448.USD","PGF"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":59,"code":"91000000","status":"200"}]}}